Literature DB >> 28399382

Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Edward P Balaban1, Pamela B Mangu1, Nelson S Yee1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28399382     DOI： 10.1200/JOP.2016.017376

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  20 in total

1.  A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.

Authors:  Mona Kamal; Xin Shelley Wang; Qiuling Shi; Tito Mendoza; Araceli Garcia-Gonzalez; Raza H Bokhari; Charles S Cleeland; David R Fogelman
Journal:  J Pain Symptom Manage       Date:  2020-01-24       Impact factor: 3.612

2.  The Art of War and oncology: applying the principles of strategy and tactics to greater effect in the era of targeted therapy.

Authors:  Emil Lou
Journal:  Ann Transl Med       Date:  2018-05

3.  Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma.

Authors:  Neal Bhutiani; Yan Li; Qianqian Zheng; Harshul Pandit; Xiaoju Shi; Yujia Chen; Youxi Yu; Zachary R Pulliam; Min Tan; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2020-07-17       Impact factor: 5.344

4.  Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance.

Authors:  Joshua S Niedzielski; Yufei Liu; Sylvia S W Ng; Rachael M Martin; Luis A Perles; Sam Beddar; Neal Rebueno; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Prajnan Das; Grace L Smith; Bruce D Minsky; Ethan B Ludmir; Joseph M Herman; Albert Koong; Gabriel O Sawakuchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-13       Impact factor: 7.038

5.  Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: a single institution experience.

Authors:  Yung-Yeh Su; Yu-Lin Ting; Chih-Jung Wang; Ying-Jui Chao; Ting-Kai Liao; Ping-Jui Su; Nai-Jung Chiang; I-Chuang Liao; Yu-Ting Yu; Yi-Sheng Liu; Hong-Ming Tsai; Yi-Jie Li; Chien-Jui Huang; I-Ting Liu; Hui-Jen Tsai; Chia-Jui Yen; Yan-Shen Shan; Li-Tzong Chen
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

6.  Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol.

Authors:  Wanrui Lv; Qingfeng Wang; Qiancheng Hu; Xin Wang; Dan Cao
Journal:  BMJ Open       Date:  2022-07-13       Impact factor: 3.006

7.  Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer.

Authors:  Walid L Shaib; Katerina Zakka; Asser A Shahin; Fares Yared; Jeffrey M Switchenko; Christina Wu; Mehmet Akce; Olatunji B Alese; Pretesh R Patel; Mark Mcdonald; Bassel F El-Rayes
Journal:  Pancreas       Date:  2020-07       Impact factor: 3.327

8.  Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer.

Authors:  Fan Lei; Xinyuan Xi; Satyanarayana Rachagani; Parthasarathy Seshacharyulu; Geoffrey A Talmon; Moorthy P Ponnusamy; Surinder K Batra; Tatiana K Bronich
Journal:  J Control Release       Date:  2020-11-18       Impact factor: 9.776

9.  New Potential Options for SBRT in Pancreatic Cancer.

Authors:  Maged Ghaly; Emile Gogineni; Joseph Herman; Muhammad W Saif
Journal:  Cancer Med J       Date:  2021-02-18

10.  Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement.

Authors:  Joshua S Jolissaint; Marsha Reyngold; Jared Bassmann; Kenneth P Seier; Mithat Gönen; Anna M Varghese; Kenneth H Yu; Wungki Park; Eileen M O'Reilly; Vinod P Balachandran; Michael I D'Angelica; Jeffrey A Drebin; T Peter Kingham; Kevin C Soares; William R Jarnagin; Christopher H Crane; Alice C Wei
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 13.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.